Infliximab improves serum adiponectin levels and endothelial dysfunction in patients with rheumatoid arthritis.

被引：0
|
作者：
Sakuta, T
Komai, N
Haruna, Y
Kuwabara, A
Horike, H
Kashihara, N
Fox, DA
Morita, Y
机构：
[1] Kawasaki Med Sch, Kurashiki, Okayama, Japan
[2] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S543 / S544
页数：2
相关论文
共 50 条
  • [41] A difference in effectiveness between infliximab, etanercept and adalimumab in patients with rheumatoid arthritis.
    Kievit, Wietske
    Fransen, Jaap
    Kuper, Ina H.
    van de Laar, Mart A. F. J.
    Jansen, Tim L.
    De Rooij, Dirk jan R. A. M.
    de Gendt, Carla M.
    Ronday, Karel H.
    Brus, Herman L. M.
    van Ooijen, Piet C. M.
    van Riel, Piet C. L. M.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S309 - S310
  • [42] RELATION BETWEEN SERUM INFLIXIMAB LEVELS AND CHANGES OF RHEUMATOID FACTOR AND ANTIBODIES TO CITRULLINATED PEPTIDES LEVELS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Estupinan, L. P. Martinez
    Valor, L.
    Hernandez, D.
    Naredo, E.
    Montoro, M.
    Nieto-Gonzalez, J. C.
    Mata-Martinez, C.
    Ovallez-Bonilla, J.
    Serrano-Benavente, B.
    Gonzalez-Fernandez, C.
    Lopez-Longo, J.
    Monteagudo, I.
    Carreno-Perez, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 938 - 938
  • [43] Infliximab treatment reduces the serum levels of interleukin-23 in patients with rheumatoid arthritis
    Kageyama, Yasunori
    Kobayashi, Hayato
    Kato, Norihiko
    MODERN RHEUMATOLOGY, 2009, 19 (06) : 657 - 662
  • [44] Elevated levels of soluble CD40 ligand in the serum of patients with rheumatoid arthritis.
    Tamura, N
    Kobayashi, S
    Bando, H
    Haruta, K
    Akimoto, T
    Sugimoto, K
    Takasaki, Y
    Hashimoto, H
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S312 - S312
  • [45] Adiponectin and leptin serum concentrations in patients with rheumatoid arthritis
    Targonska-Stepniak, Bozena
    Dryglewska, Magdalena
    Majdan, Maria
    RHEUMATOLOGY INTERNATIONAL, 2010, 30 (06) : 731 - 737
  • [46] Increased serum levels of total IgE as a marker of severe evolution in patients with rheumatoid arthritis.
    Agache, I
    Duca, L
    Leasu, F
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S128 - S129
  • [47] Infliximab in rheumatoid arthritis. Why do patients warrant dose increases?
    Haraoui, P
    Cameron, L
    Ouellet, M
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 298 - 298
  • [48] Positive effects of infliximab therapy on bone metabolism in patients with rheumatoid arthritis.
    Thomas, T
    Garnero, P
    le Henanff, A
    Debiais, F
    Le Loet, X
    Roux, C
    Sany, J
    Wendling, D
    Zarnitsky, C
    Ravaux, P
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S333 - S333
  • [49] Serum YKL-40 levels in patients with unclassified polyarthritis and early rheumatoid arthritis.
    Johansen, JS
    Klarlund, M
    Price, PA
    Jensen, KE
    Skjodt, H
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S155 - S155
  • [50] Predictors of Endothelial Dysfunction in Patients With Rheumatoid Arthritis
    Sarli, Bahadir
    Baktir, Ahmet Oguz
    Cebicci, Mehtap
    Dogan, Yasemin
    Demirbas, Melih
    Kurtul, Serkan
    Saglam, Hayrettin
    Akpek, Mahmut
    Sahin, Omer
    Arinc, Huseyin
    ANGIOLOGY, 2014, 65 (09) : 778 - 782
12345